Stocks

Ligand Pharmaceuticals LGND

Health care sectorNasdaq

What to see in Ligand Pharmaceuticals now

Is Wall Street adding or cutting?+56

415 13F filers hold it · +56 against the quarter before · shares held +8.9%

Holdings of 06/30
Who bought more than 5%?6.1%

Invesco holds 6.1%

Filed 08/13
Is stock about to come to market?$4.6M

$4.6M of planned sales filed in 30 days · 0.1% of the units outstanding

Filed 09/10

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
San Diego, California
Fiscal year end
12/31
Next earnings
11/05, estimated
  • 415 13F filers hold it · +56 against the quarter before · shares held +8.9%Holdings of 06/30
  • Invesco holds 6.1%Filed 08/13

Funds

13F filers: 415 · +56 since the quarter before · 06/30 holdings

Famous funds that held Ligand Pharmaceuticals in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsLigand Pharmaceuticals LGND · 06/30 holdings$2.9MNo quarter before
Mirae Asset Global InvestmentsLigand Pharmaceuticals LGND · 06/30 holdings$283.2KTrimmed −13.8%
All tracked funds

5% stakes

Holder
Invesco08/136.1%1,218,846 shFirst report
Vanguard Portfolio Management05/015.56%1,109,154 shFirst report
Vanguard Capital Management05/015%997,637 shFirst report
BlackRock25/10/1714.5%2,839,251 sh−1.1pp
All 5% stake reports on Ligand Pharmaceuticals

26-week trading

Common questions

Which members of Congress traded Ligand Pharmaceuticals LGND recently?
The latest reported trades: Rep. Gilbert Cisneros, purchase on 05/29 (reported 06/08), Rep. Gilbert Cisneros, purchase on 03/03 (reported 04/07), Rep. Gilbert Cisneros, purchase on 01/15 (reported 02/13) and Rep. Gilbert Cisneros, purchase on 01/05 (reported 02/13).